Immunocore Holdings plc
IMCR
$30.73
$0.160.52%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
10/27/2025
-
MarketBeat
3/17/2026
-
Globe Newswire
3/16/2026
-
MarketBeat
3/13/2026
-
Ticker Report
3/13/2026
-
Tickeron - Stocks
3/13/2026
-
Tickeron - Stocks
3/13/2026
-
Tickeron - Stocks
3/12/2026
-
Tickeron - Stocks
3/11/2026
-
Tickeron - Stocks
3/10/2026
-
Simply Wall St
3/10/2026
-
Tickeron - Technical Analysis
3/6/2026
-
MarketBeat
Assessing Immunocore (IMCR) Valuation After Earnings Show Revenue Growth And Narrower Full Year Loss
3/6/2026
-
Simply Wall St
3/6/2026
-
MarketBeat
3/6/2026
-
Tickeron - Stocks
3/6/2026
-
Tickeron - Stocks
3/5/2026
-
MarketBeat
3/5/2026
-
CNW Group - News Releases
3/5/2026
-
PR Newswire
3/5/2026
-
Tickeron - Stocks
3/4/2026
-
Tickeron - Stocks
3/3/2026
-
Globe Newswire
3/3/2026
-
Simply Wall St
2/28/2026
-
Simply Wall St
2/27/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, February 25, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
44 12 3543 8600
Address
92 Park Drive
Abingdon, OX14 4RY
Abingdon, OX14 4RY
Country
Year Founded
Business Description
Sector
Immunocore Holdings plc, together with its subsidiaries, engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and...
more